Epstein-Barr virus (EBV) is a ubiquitous human pathogen associated with Burkitt's
lymphoma and nasopharyngeal carcinoma. Although the EBV genome harbors more than a …

Highlights•EBV encodes viral epigenetic effectors that alter viral and host epigenomes.•EBV-
induced epigenetic changes to the host epigenome have oncogenic consequences.• …

Epstein-Barr virus (EBV) reactivation involves the ordered induction of approximately 90
viral genes that participate in the generation of infectious virions. Using strand-specific RNA …

Simple Summary Epstein–Barr virus (EBV) was first isolated in 1964 and has since become
an important human tumor virus. With an estimated 90% of the human population infected …

Epstein–Barr virus (EBV) is the causative agent of infectious mononucleosis and a risk factor
for developing a variety of lymphomas and carcinomas. EBV nuclear antigen 1 (EBNA1) is …

ABSTRACT The Epstein-Barr virus (EBV) lytic phase, like those of all herpesviruses,
proceeds via an orderly cascade that integrates DNA replication and gene expression. EBV …

Infection with Epstein–Barr virus (EBV) usually leads to a latent state in B lymphocytes. The
virus can be reactivated through two viral transactivators, Zta and Rta, leading to a cascade …

Epstein-Barr virus (EBV) is associated with malignant diseases of lymphoid and epithelial
cell origin. The tropism of EBV is due to B-cell-restricted expression of CD21, the major …

ABSTRACT EBNA 1 is the only antigen expressed in both Epstein-Barr virus (EBV)-infected
nasopharyngeal carcinoma (NPC) and Burkitt's lymphoma cells. Previous studies showed …

Epstein–Barr virus (EBV), a human herpesvirus, is associated with a wide variety of
malignant tumors. The expression of the latent viral RNAs is under strict, host-cell dependent …